Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usage.

Besides routine pharmacokinetic (PK) parameters, unbound brain-to-blood concentration ratio (K) is an index particularly crucial in drug discovery for central nervous system (CNS) indications. Despite advantages of K from steady state after constant intravenous (i.v.